Carlos C Cardo

Title: The Innovations of Carlos C. Cardo

Introduction

Carlos C. Cardo is a notable inventor based in New York, NY, recognized for his contributions to the field of cancer research. He has developed significant innovations that have the potential to impact cancer diagnostics and treatment.

Latest Patents

Carlos C. Cardo holds a patent for "Human monoclonal antibodies to cell surface antigens." This patent discloses human monoclonal antibodies (HmAbs) capable of reacting with cell surface antigens and intracellular components. The HmAbs Ev248, Ch-5, Ch-13, Te-39, Hu44, Ge-1, Gr-431, Gr169, and Sp909 have been identified as useful for detecting these antigens in various cells. The ability to determine malignant cells using these HmAbs can significantly aid in screening metastasized tumors and primary tumors for tissue source, thereby greatly affecting cancer management.

Career Highlights

Carlos C. Cardo is affiliated with the Sloan-Kettering Institute for Cancer Research, where he continues to advance his research and innovations in cancer treatment. His work is pivotal in the ongoing battle against cancer, providing new tools for diagnosis and therapy.

Collaborations

Some of his notable coworkers include Richard J. Cote and Timothy M. Thomson, who contribute to the collaborative efforts in cancer research at the institute.

Conclusion

Carlos C. Cardo's work exemplifies the intersection of innovation and healthcare, particularly in the realm of cancer research. His contributions through patents and collaborations are vital for advancing cancer diagnostics and treatment strategies.